Pet and livestock drug company Zoetis, which prevailed in its defence to a class action over horse vaccine Equivac, is going after the legal team that ran the unfunded case, seeking orders that the lawyers pay a big portion of its $3.8 million legal bill.
The Full Federal Court has set aside a $150,000 defamation judgment for sports presenter Erin Molan and remitted the matter for a new trial, after finding a judge failed to properly consider publisher the Daily Mail’s defence of contextual truth.
The Daily Mail has argued that Nine sports presenter Erin Molan should be stripped of a $150,000 defamation damages award because of her history of “seriously egregious conduct” on 2GB’s Continuous Call Team radio show.
US tool giant Illinois Tool Works has defeated an appeal to a ruling that found Australian tool company Airco infringed it patent for a fuel cell designed for use in combustion tools.
The Australian Competition and Consumer Commission has won its appeal against Employsure over alleged misleading Google advertisements, with the Full Federal Court upping the penalty against the specialist workplace relations consultancy from $1 million to $3 million.
From the ongoing saga of the high-profile Christian Porter action against the ABC to “backyard” litigation testing the serious harm bar, defamation cases made headlines in 2022, with winners and losers alike shelling out millions to lawyers to protect their reputations.
The applicant who lost a class action against animal health giant Zoetis over alleged side effects resulting from its Hendra virus horse vaccine has filed an appeal, arguing the judge should have found the vaccine was not of acceptable quality.
A psychiatrist that sued HarperCollins for defamation over a book on the use of deep sleep therapy at the Chelmsford Private Hospital in the 1970s has lost his bid to disallow the publisher’s claim that any damage he suffered was mitigated by his bad reputation.
A judge has found the applicant in a dismissed class action against animal health giant Zoetis is liable for the company’s defence costs in the case centering on alleged serious side effects of horse vaccine Equivac.
Boral has won its bid to shield from shareholders in a class action three investigative reports, including one by accounting giant EY, concerning financial irregularities in the construction company’s North America windows business.